Early Gut Microbiome Sets Stage for Lifelong Health in First 3 Years
Comprehensive review reveals how infant gut bacteria development in first 1000 days determines chronic disease risk throughout life.
5536 articles
Comprehensive review reveals how infant gut bacteria development in first 1000 days determines chronic disease risk throughout life.
New review reveals how senescent brain cells fuel Alzheimer's progression and highlights promising senolytic therapies for cognitive protection.
Dasatinib and quercetin nanoparticles improve egg quality and fertility in aging mouse ovaries by clearing senescent cells.
Comprehensive review maps molecular pathways driving vascular dementia, highlighting novel therapeutic approaches.
New research reveals how chronic inflammation varies by person, paving the way for personalized interventions to combat age-related diseases.
New study shows DunedinPACE aging biomarker can predict who will develop metabolic syndrome years in advance, outperforming other epigenetic clocks.
Men with Klinefelter syndrome (XXY) show reduced epigenetic aging compared to typical XY males, challenging assumptions about chromosome disorders.
Leading researchers identify key challenges in validating aging biomarkers for clinical use, emphasizing need for longitudinal studies.
Study of 2,366 women shows biological aging markers predict future increases in tau, amyloid, and neuroinflammation proteins linked to dementia.
New research explores how epigenetic modifications control the aging process and potential therapeutic targets.
New research reveals how a mitochondrial enzyme enhances immune cell function to fight bacterial lung infections and reduce inflammation.
German registry reveals physicians start most patients on lower-than-recommended doses of new long-acting growth hormone therapies.